{"clinical_study": {"@rank": "56", "required_header": {"download_date": "ClinicalTrials.gov processed this data on April 03, 2020", "link_text": "Link to the current ClinicalTrials.gov record.", "url": "https://clinicaltrials.gov/show/NCT04312464"}, "id_info": {"org_study_id": "MD-COVID-19", "nct_id": "NCT04312464"}, "brief_title": "Myocardial Damage in COVID-19", "official_title": "Retrospective Study of Myocardial Damage in COVID-19", "sponsors": {"lead_sponsor": {"agency": "Wuhan Union Hospital, China", "agency_class": "Other"}}, "source": "Wuhan Union Hospital, China", "oversight_info": {"is_fda_regulated_drug": "No", "is_fda_regulated_device": "No"}, "brief_summary": {"textblock": "This study aims to investigate the clinical characteristics, the incidence of myocardial\n      injury, and the influence of myocardial injury on the prognosis in COVID-19 patients. There\n      is no additional examination and treatment for this project."}, "detailed_description": {"textblock": "The epidemic of the COVID-19 has expanded from Wuhan through out China, and is being exported\n      to a growing number of countries. Recently, investigators have revealed that acute myocardial\n      injury is existed in 7.2% patients with COVID-19, and this proportion in patients admitted to\n      the ICU (22.2%) is higher than patients not treated in the ICU (2.0%). Thus, cardiac troponin\n      I (cTNI), the biomarker of cardiac injury, might be a clinical predictor of COVID-19 patient\n      outcomes. This study aims to investigate the clinical characteristics, the incidence of\n      myocardial injury, and the influence of myocardial injury on the prognosis in COVID-19\n      patients."}, "overall_status": "Enrolling by invitation", "start_date": {"@type": "Actual", "#text": "January 1, 2020"}, "completion_date": {"@type": "Anticipated", "#text": "March 18, 2020"}, "primary_completion_date": {"@type": "Anticipated", "#text": "March 15, 2020"}, "study_type": "Observational", "has_expanded_access": "No", "study_design_info": {"observational_model": "Case-Control", "time_perspective": "Retrospective"}, "primary_outcome": [{"measure": "The myocardial injury incidence", "time_frame": "75 days", "description": "The myocardial injury incidence of COVID-19 patients"}, {"measure": "The risk factors analysis for the death", "time_frame": "75 days", "description": "The risk factors analysis for the death of COVID-19 patients"}], "secondary_outcome": [{"measure": "Clinical characteristics", "time_frame": "75 days", "description": "The clinical characteristics description of COVID-19 patients"}, {"measure": "Clinical course", "time_frame": "75 days", "description": "The clinical course description of COVID-19 patients"}, {"measure": "Cardiovascular comorbidity", "time_frame": "75 days", "description": "The clinical characteristics and prognosis analysis in different cardiovascular comorbidity of COVID-19 patients"}, {"measure": "Analysis of causes of death", "time_frame": "75 days", "description": "Analysis of causes of death in COVID-19 patients"}], "number_of_groups": "2", "enrollment": {"@type": "Anticipated", "#text": "500"}, "condition": ["COVID-19", "Cardiovascular Diseases"], "arm_group": [{"arm_group_label": "Discharged group", "description": "The individual which is defined as patient discharged from hospital"}, {"arm_group_label": "Dead group", "description": "The individual which is defined as patient with all-cause death"}], "intervention": {"intervention_type": "Other", "intervention_name": "non", "description": "no intervention", "arm_group_label": ["Dead group", "Discharged group"]}, "eligibility": {"study_pop": {"textblock": "The laboratory-confirmed patients with confirmed COVID-19 admitted to headquarters, west\n        campus and cancer center of Union Hospital, Tongji Medical College, Huazhong University of\n        science and technology, from January 1st to March 15th, 2020"}, "sampling_method": "Probability Sample", "criteria": {"textblock": "Inclusion Criteria:\n\n          -  (1) Age \u226518 years. (2) Laboratory (RT-PCR) confirmed infection with SARS-CoV-2. (3)\n             Lung involvement confirmed with chest imaging.\n\n        Exclusion Criteria:\n\n          -  No cTnI test on admission"}, "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No"}, "location": {"facility": {"name": "Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "address": {"city": "Wuhan", "state": "Hubei", "zip": "430022", "country": "China"}}}, "location_countries": {"country": "China"}, "verification_date": "March 2020", "study_first_submitted": "March 4, 2020", "study_first_submitted_qc": "March 13, 2020", "study_first_posted": {"@type": "Actual", "#text": "March 18, 2020"}, "last_update_submitted": "March 13, 2020", "last_update_submitted_qc": "March 13, 2020", "last_update_posted": {"@type": "Actual", "#text": "March 18, 2020"}, "responsible_party": {"responsible_party_type": "Principal Investigator", "investigator_affiliation": "Wuhan Union Hospital, China", "investigator_full_name": "Xiang Cheng", "investigator_title": "Professor"}, "keyword": ["COVID-19", "myocardial injury"], "condition_browse": {"mesh_term": "Cardiovascular Diseases"}}}